Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sudden unexpected death in epilepsy: is carbamazepine implicated?

P L Timmings1

  • 1Waikato Hospital, Hamilton, New Zealand.

Seizure
|September 11, 1998
PubMed
Summary

Sudden unexpected death in epilepsy (SUDEP) may be linked to carbamazepine, an antiepileptic drug. Further research is needed to confirm carbamazepine

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sudden unexpected death in epilepsy: a local audit.

Seizure·1993
Same author

Wernicke's encephalopathy presenting with blindness.

The New Zealand medical journal·1993
Same author

Juvenile myoclonic epilepsy.

BMJ (Clinical research ed.)·1992
Same author

Lamotrigine in primary generalised epilepsy.

Lancet (London, England)·1992
Same author

Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome.

European neurology·1992
Same author

Impairment of high-contrast visual acuity in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society·1992

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Sudden unexpected death in epilepsy (SUDEP) is a recognized but poorly understood complication of epilepsy.
  • Accurate identification and reporting of SUDEP are crucial for further research and understanding.
  • The incidence of SUDEP may be increasing due to better recognition or a genuine rise.

Purpose of the Study:

  • To investigate the potential association between antiepileptic drug (AED) usage and SUDEP.
  • To examine the specific role of carbamazepine in SUDEP cases.
  • To highlight the need for improved SUDEP documentation and research.

Main Methods:

  • Review of data from the Cardiff Epilepsy Unit, focusing on patients who died from SUDEP.
  • Analysis of AED usage in SUDEP patients compared to the general epilepsy patient population.
  • Statistical analysis to determine the significance of carbamazepine association (P < 0.01).

Main Results:

  • Carbamazepine was disproportionately represented in patients who died from SUDEP.
  • In the reviewed series, 79% of SUDEP patients were taking carbamazepine, significantly higher than the average usage of 38%.
  • Excluding one non-drug-treated patient, the proportion taking carbamazepine rose to 85%.

Conclusions:

  • Current knowledge of SUDEP mechanisms and contributing factors remains limited.
  • Improved medical education is essential for accurate SUDEP case ascertainment and reporting.
  • Carbamazepine warrants further evaluation as a potential significant factor in SUDEP, possibly through cardiac or respiratory mechanisms.

Related Experiment Videos